WST
West Pharmaceutical Services, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +1.8% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 160 | +3 | 50.04M | $17.95B | +8 | −6 |
| Q1 2026 | 161 | -2 | 49.75M | $12.46B | +4 | −7 |
| Q4 2025 | 162 | +3 | 53.70M | $14.74B | +5 | −1 |
| Q3 2025 | 21 | -1 | 26.99M | $7.08B | — | −2 |
| Q2 2025 | 20 | 0 | 24.84M | $5.43B | +1 | −1 |
| Q1 2025 | 17 | +2 | 8.37M | $1.87B | +2 | — |
| Q4 2024 | 15 | +2 | 8.55M | $2.80B | +2 | — |
| Q3 2024 | 12 | -1 | 4.43M | $1.33B | — | −1 |
| Q2 2024 | 13 | — | 5.33M | $1.75B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 9.32M | — | $2.04B | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passief) | 6.60M | — | $1.45B | 0.0% | n/c | 1 | SEC ↗ ×21 |
| 3 | State Street Global Advisors ✦ (passief) | 3.27M | +2.1% | $715.88M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 1.83M | -1.1% | $399.36M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passief) | 917.79K | +1.6% | $200.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 584.07K | +11.7% | $127.79M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 7 | Millennium Management ✦ | 465.59K | +53.0% | $101.87M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Gates Foundation Trust ✦ | 444.50K | 0.0% | $97.26M | 0.2% | Held | 2 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 339.95K | +165.0% | $74.38M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 284.34K | +176.0% | $62.21M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Arrowstreet Capital ✦ | 129.03K | +212.0% | $28.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 128.79K | -54.1% | $28.18M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 13 | T. Rowe Price ✦ | 117.63K | -24.0% | $25.74M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | AQR Capital Management ✦ | 104.95K | +2295.6% | $22.96M | 0.0% | ▲ Add | 5 | SEC ↗ ×6 |
| 15 | Fidelity (FMR) ✦ | 104.78K | — | $22.93M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 16 | Adage Capital Partners ✦ | 65.81K | -68.8% | $14.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Marshall Wace ✦ | 62.53K | -62.4% | $13.68M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 18 | Fisher Asset Management ✦ | 24.34K | -17.0% | $5.33M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 24.30K | Nieuw | $5.32M | 0.0% | New | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 13.81K | +2.3% | $3.02M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $5.32M | 0.0% |
Verlaten
| Gotham Asset Management | $467,909 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 749 houders, 70.07M aandelen, $16.37B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 2.52K aand · $921,260
Officer · 2.50K aand · $887,500
Officer · 2.50K aand · $862,500
Officer · 2.82K aand · $960,062
Officer · 2.82K aand · $960,403
Officer · 2.50K aand · $852,025
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie